:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Chakraborty, Chiranjib, Lo, Yi-Hao, Bhattacharya, Manojit, Das, Arpita, Wen, Zhi-Hong
Format:	Artículo científico
Language:	en
Published:	Molecular therapy. Nucleic acids 2025
Online Access:	https://pubmed.ncbi.nlm.nih.gov/40291378/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deep learning in next-generation vaccine development for infectious diseases.
by: Bhattacharya, Manojit, et al.
Published: (2025)

Regulation of miRNA in Cytokine Storm (CS) of COVID‐19 and Other Viral Infection: An Exhaustive Review
by: Chiranjib Chakraborty, et al.
Published: (2025)

Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review
by: Chiranjib Chakraborty, et al.
Published: (2024)

Understanding the landscape of cross-species transmission, epidemiology, phylogenetics, and antigenicity of HPAI strain A(H5N1) causing a recent outbreak in the USA.
by: Chakraborty, Chiranjib, et al.
Published: (2025)

Quercetin, Isoquercitrin, and Quercetin‐3‐Rutinoside: Understanding the Pharmacological, Organoleptic, ADME Properties, Human Health Toxicity, Ecological Risk, and Cosmetic Risk of Using Integrative Bioinformatics
by: Anirban Debnath, et al.
Published: (2025)

Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives
by: Srijan Chatterjee, et al.
Published: (2024)

The discovery, origins and evolution of SARS-CoV-2 (COVID-19)
by: Holmes, Edward C
Published: (2021)

Comprehensive global-scale evaluation of the COVID-19 pandemic associated with 234 countries, territories, and sub-national locations during 2020-2024.
by: Chakraborty, Chiranjib, et al.
Published: (2025)

Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
by: Nicole L Messina, et al.
Published: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

COVID-19 y SARS-CoV-2
by: Alfredo Pinzón-Junca
Published: (2020)

The characteristics of BCR‐CDR3 repertoire in COVID‐19 patients and SARS‐CoV‐2 vaccinated volunteers
by: Jiaping Xiao, et al.
Published: (2024)

Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID ‐19 vaccination
by: Ilya Kister, et al.
Published: (2024)

Nationwide estimates of SARS‐CoV‐2 infection fatality rates and numbers needed to vaccinate for COVID‐19 vaccines in 2024 in Austria
by: Uwe Riedmann, et al.
Published: (2025)

Safety and immunogenicity of vaccines against SARS-CoV-2
by: Francisco Xavier Poveda Paredes
Published: (2021)

Current Topics in SARS-CoV-2/COVID-19
Published: (2023)

Monte Carlo simulation of SARS-CoV-2 radiation-induced inactivation for vaccine development
by: Francis, Ziad, et al.
Published: (2020)

Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review
by: Lina Sofía Morón-Duarte
Published: (2022)

Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia
by: Carlos Reina
Published: (2021)

Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population
by: George Cavic, et al.
Published: (2024)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
by: Alexandre Hassanin, et al.
Published: (2024)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
by: Nicolas Capelli, et al.
Published: (2024)

Effect of COVID 19 vaccination on the CT severity score for SARS CoV2 pneumonia- an experience from the initial wave
by: R. Batra
Published: (2023)

Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases
by: B. Levian, et al.
Published: (2024)

SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia
by: Danchen Wu, et al.
Published: (2026)

Subacute thyroiditis after SARS‐CoV‐2 vaccination: A case report
by: Ozra Akha, et al.
Published: (2024)

Lung damage in SARS ‐ CoV ‐2 patients: An autopsy study in the era of vaccination
by: Rossana Bussani, et al.
Published: (2024)

Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination
by: Andrea Pilotto, et al.
Published: (2024)

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
by: Liu, Jia, et al.
Published: (2020)

SARS-CoV-2: structure, replication and pathophysiological mechanisms related to COVID-19
by: Arandia Guzmán Jaime
Published: (2020)

Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2
by: Arthur K. Melkonian, et al.
Published: (2024)

The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID
by: Daniel W Thorpe, et al.
Published: (2026)

Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study
by: César Fernández‐de‐las‐Peñas, et al.
Published: (2024)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Correction to ‘Lung damage in SARS ‐ CoV ‐2 patients: An autopsy study in the era of vaccination’
Published: (2025)

Incremental immunogenicity of multiple doses of SARS‐CoV‐2 vaccination in patients with haematological malignancies
by: Abi Vijenthira, et al.
Published: (2025)

Preexisting symptoms increase the risk of developing long COVID during the SARS‐CoV‐2 pandemic
by: Vincent Lak, et al.
Published: (2025)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel
Published: (2020)

Anticoagulación en pacientes con infección por SARS-CoV-2/COVID-19
by: Emilio Abuabara-Franco
Published: (2020)